ONE-WAYOngoing theme · still written in the latest filings
Expanding the Evidence Solutions Business
An ongoing theme focused on expanding the evidence solutions business by combining CRO and SMO services, large-scale clinical research, and drug development support in Asia, while pursuing revenue and profit growth through the acquisition of high-margin projects.
Companies9How many companies write about this.
Threads12One company can carry more than one thread here.
PeriodFY2016 →Still being written about.
Directionhelps10 helps · 2 hurts · 0 flat